Latest News & Features
Refine Search
Americas
US life sciences analysis company Sequenom has agreed a multi-million dollar deal to buy patents related to prenatal testing from UK-based technology transfer company Isis Innovation. 7 October 2014
Big Pharma
Drug business Teva invalidated two patents held by Leo Pharma today and will seek to launch a generic version of one of the company’s skin condition treatments. 6 October 2014
Big Pharma
Pharmaceutical company CleveXel Pharma has agreed a deal with a technology transfer company to licence two patents related to the treatment of bone marrow cancer. 6 October 2014
Americas
Law firm Blank Rome has expanded its litigation department with the appointment of life science specialist and partner Gary Ruckelshaus. 3 October 2014
Americas
US-based specialty drugs company Supernus Pharmaceuticals has sued generics maker Actavis, accusing it of infringing three patents related to an antiepileptic drug. 3 October 2014
Americas
Biopharmaceutical company Opexa Therapeutics has expanded its IP portfolio to include nearly 100 validated patents worldwide, the company has said. 1 October 2014
Americas
Healthcare advocate Médecins Sans Frontières has urged Indian Prime Minister Narendra Modi not to change IP laws which allow for the production of generic medicines. 30 September 2014
Americas
Research organisation Horizon Discovery Group has bought Sage Labs in a deal worth almost $50 million, a move that will strengthen its IP portfolio, the company has announced. 29 September 2014
Americas
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed. 26 September 2014